The Smolka Lab, led by Prof. Marcus Smolka, molecular biology and genetics, recently published a study shedding light on a novel pathway that explains how cancer cells can become resistant to ...
Mayo Clinic researchers and collaborators have identified a previously unrecognized way lung tumors weaken the immune system, ...
According to recent reports from the Korean government, the incidence of alcoholic liver disease—previously the leading indication for liver transplantation—has been decreasing. This trend initially ...
When cancer cells mutate, they produce small peptides called neoantigens. Because neoantigens remain relatively unique to tumors, they can provide a marker to help the immune system recognize and kill ...
One strategy tumors use to ensure survival involves interfering with our inherent immune response. Effective anti-tumor immunity should identify and eliminate foreign, damaged, or dying cells before ...
As is often the case with cancer treatments, many patients are able to benefit from therapy for a time. Tumor activity ...
When researchers at the University of Michigan Rogel Cancer Center first identified a new subtype of aggressive prostate cancer, they knew they needed to understand how this genetic alteration was ...
Cellular findings show Telomir-Zn modulates intracellular metal balance linked to oxidative stress, mitochondrial dysfunction, DNA methylation instability, and genomic integrity-without relying on ...
Imagine that two women have breast cancer with the same subtype: hormone receptor positive (HR+) and human epidermal growth factor receptor 2 negative (HER2-). They’re the same age, weight, and height ...
FDA fast track covers ART6043 plus olaparib in PARP inhibitor–naïve gBRCAm, HER2-negative locally advanced/metastatic breast ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results